How much does Certara cost?

Certara does not publish a price list. Pricing is quoted per account, so the figure depends on seats, volume and contract length. Ask for a written quote covering renewal as well as year one.

Does Certara have a free trial or free plan?

No. Certara offers neither a free plan nor a free trial, so evaluation happens through a demo.

Certara is aimed at medium Business, Large Enterprise.

How is Certara deployed?

Certara is deployed as cloud based and on premise, and available on Web App, Windows.

What support does Certara include?

Certara provides email, phone support.

Does Certara offer an API?

Yes. Certara exposes an API, so it can exchange data with the other systems you already run rather than sitting on its own.

Certara

Biosimulation and regulatory software spanning discovery to market access

Life Sciences Software

Deployment Cloud Based, On Premise
Starting price Quoted on request
Free trial Not offered
Best for Medium Business, Large Enterprise

What is Certara?

Certara sells drug development software organised by development phase rather than by technical function, which makes it unusually easy to place against a pipeline. Its solutions run from discovery through preclinical, early clinical and late clinical to market access and commercial, with regulatory strategy running alongside. The vendor combines science, technology, and strategic and regulatory expertise, so software is sold with consulting rather than as a standalone licence.

Model-Informed Drug Development is the intellectual core. The argument is that predictive modelling reduces development risk and accelerates decisions, so candidates are refined and go or no-go calls made earlier, when they cost less. Simcyp applies physiologically based pharmacokinetic modelling to predict drug behaviour across diverse populations, which matters for dosing in groups rarely represented in trials. Phoenix handles pharmacokinetic, pharmacodynamic and toxicokinetic analysis and modelling. Early clinical work uses simulation for first-in-human success and precision dosing, and preclinical work uses predictive modelling and dosing optimisation to streamline IND submissions.

The regulatory and data tools address the submission itself. Pinnacle 21 covers data standardisation and validation against recognised standards, GlobalSubmit publishes, reviews and transmits eCTD submissions to health authorities, and CoAuthor applies generative AI, templates and structured content to regulatory writing. SEND Explorer visualises nonclinical data for trends and outliers. On the science side, D360 provides scientific informatics for accessing and visualising molecule and bioactivity data, Chemaxon supplies chemical and biological intelligence, and Certara IQ integrates biological and pharmacological insight to optimise efficacy and safety predictions. BaseCase builds interactive value stories for market access, and Certara.AI is the AI platform across the portfolio. A Non-Animal Navigator addresses the shift away from animal testing. Pricing is not published.